The influence of reactive oxygen species on the central nervous system;Wpływ reaktywnych form tlenu na ośrodkowy układ nerwowy

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 65, Issue , 2011, Pages 104-113

  Gutowicz, Marzena ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Central nervous system; Oxidative stress; Reactive oxygen species

Indexed keywords

EID: 79958865122     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.933486     Document Type: Review

References (111)

1. Adibhatla R.M., Hatcher J.F.: Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal., 2010; 12: 125-169.
2. Adler V., Yin Z., Tew K., Ronai Z.: Role of redox potential and reactive oxygen species in stress signaling. Oncogene, 1999; 18: 6104-6111.
3. Afanas'ev I.B.: Free radical mechanisms of aging processes under physiological conditions. Biogerontology, 2005; 6: 283-290. (Pubitemid 43118467)
4. Agar J., Durham H.: Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph. Lateral Scler. Other Motor Neuron Disord., 2003; 4: 232-242. (Pubitemid 37428478)
5. Alessandri J.M., Guesnet P., Vancassel S., Astorg P., Denis I., Langelier B., Aïd S., Poumès-Ballihaut C., Champeil-Potokar G., Lavialle M.: Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev., 2004; 44: 509-538. (Pubitemid 40309154)
6. Alper G., Girgin F.K., Ozgönül M., Mentes G., Ersöz B.: MAO inhibitors and oxidant stress in aging brain tissue. Eur. Neuropsychopharmacol., 1999; 9: 247-252. (Pubitemid 29114931)
7. Amitai Y.: Physiologic role for "inducible" nitric oxide synthase: A new form of astrocytic-neuronal interface. Glia, 2010; 58: 1775-1781.
8. Andreoli T.E.: Free radicals and oxidative stress. Am. J. Med., 2000; 108: 650-651. (Pubitemid 30336604)
9. Attwell D., Iadecola C.: The neural basis of functional brain imaging signals. Trends Neurosci., 2002; 25: 621-662.
10. Ball S.: Chemia szarych komórek. Neurochemia i toksykologia osrodkowego ukladu nerwowego. Medyk Sp. z o. o. Warszawa 2003.
11. Bartosz G.: Druga twarz tlenu. Wolne rodniki w przyrodzie. Wydawnictwo Naukowe PWN. Warszawa 2006.
12. Beal M.F.: Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol., 1995; 38: 357-366.
13. Beckman K.B., Ames B.N.: Endogenous oxidative damage of mtDNA. Mutat. Res., 1999; 424: 51-58. (Pubitemid 29101607)
14. Benedetti M.D., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., Schaid D.J., Rocca W.A.: Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology, 2000; 55: 1350-1358.
15. Berg D., Youdim B.H., Riederer P.: Redox imbalance. Cell Tissue Res. 2004; 318: 201-213. (Pubitemid 39362641)
16. Berlett B.S., Stadtman E.R.: Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem., 1997; 272: 20313-20316. (Pubitemid 27355575)
17. Brenna J.T., Diau G.Y.: The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot. Essent. Fatty Acids, 2007; 77: 247-250. (Pubitemid 350198855)
18. Bruce-Keller A.J., Li Y.J., Lovell M.A., Kraemer P.J., Gary D.S., Brown R.R., Markesbery W.R., Mattson M.P.: 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol., 1998; 57: 257-267. (Pubitemid 28125506)
19. Butterfield D.A., Lauderback C.M.: Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med., 2002; 32: 1050-1060. (Pubitemid 34603342)
20. Cadenas E.: Mitochondrial free radical production and cell signaling. Mol. Aspects Med., 2004; 25: 17-26. (Pubitemid 38401928)
21. Cadet J.L., Brannock C.: Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int., 1998; 32: 117-131. (Pubitemid 28105298)
22. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B.: In-vivo measurement of activated microglia in dementia. Lancet, 2001; 358: 461-467. (Pubitemid 32769854)
23. Calabrese V., Scapagnini G., Ravagna A., Bella R., Butterfield D.A., Calvani M., Pennisi G., Giuffrida Stella A.M.: Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine. Neurochem. Res., 2003; 28: 1321-1328. (Pubitemid 38113060)
24. Chakraborti S., Chakraborti T.: Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system: a brief overview. Cell Signal., 1998; 10: 675-683. (Pubitemid 28520019)
25. Chavko M., Auker C.R., McCarron R.M.: Relationship between protein nitration and oxidation and development of hyperoxic seizures. Nitric Oxide, 2003; 9: 18-23. (Pubitemid 37237689)
26. Chen C.M., Wu Y.R., Cheng M.L., Liu J.L., Lee Y.M., Lee P.W., Soong B.W., Chiu D.T.: Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients. Biochem Biophys. Res. Commun., 2007; 359: 335-340. (Pubitemid 46880509)
27. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A.: 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J. Biol. Chem., 1992; 267: 166-172.
28. Chong Z.Z., Li F., Maiese K.: Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease. Prog. Neurobiol., 2005; 75: 207-246. (Pubitemid 40693131)
29. Ciolino H.P., Levine R.L.: Modification of proteins in endothelial cell death during oxidative stress. Free Radic. Biol. Med., 1997; 22: 1277-1282. (Pubitemid 27171970)
30. Conner E.M., Grisham M.B.: Inflammation, free radicals, and antioxidants. Nutrition, 1996; 12: 274-277. (Pubitemid 126746204)
31. Cookson M.R., Shaw P.J.: Oxidative stress and motor neurone disease. Brain Pathol., 1999; 9: 165-186. (Pubitemid 29056526)
32. Dawson V.L., Dawson T.M.: Nitric oxide in neuronal degeneration. Proc. Soc. Exp. Biol. Med., 1996; 211: 33-40. (Pubitemid 26029150)
33. Delanty N., Dichter M.A.: Oxidative injury in the nervous system. Acta Neurol. Scand., 1998; 98: 145-153. (Pubitemid 28435306)
34. de Menezes C.C., Dorneles A.G., Sperotto R.L., Duarte M.M., Schetinger M.R., Loro V.L.: Oxidative stress in cerebrospinal fluid of patients with aseptic and bacterial meningitis. Neurochem. Res., 2009; 34: 1255-1260.
35. Denicola A., Radi R.: Peroxynitrite and drug-dependent toxicity. Toxicology, 2005; 208: 273-288. (Pubitemid 40187337)
36. Di Stasi A.M., Mallozzi C., Macchia G., Petrucci T.C., Minetti M.: Peroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins. J. Neurochem., 1999; 73: 727-735. (Pubitemid 29339847)
37. Dix T.A., Aikens J.: Mechanisms and biological relevance of lipid peroxidation initiation. Chem. Res. Toxicol., 1993; 6: 2-18. (Pubitemid 23040365)
38. Dmitriev L.F.: The involvement of lipid radical cycles and the adenine nucleotide translocator in neurodegenerative diseases. J. Alzheimers Dis., 2007; 11: 183-190. (Pubitemid 47010985)
39. Dröge W.: Free radicals in the physiological control of cell function. Physiol. Rev., 2002; 82: 47-95. (Pubitemid 34654215)
40. Elliott J.L.: Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2001; 25: 1169-1185. (Pubitemid 32835278)
41. Faraci F.M.: Reactive oxygen species: influence on cerebral vascular tone. J. Appl. Physiol., 2006; 100: 739-743. (Pubitemid 43671633)
42. Fiskum G., Murphy A.N., Beal M.F.: Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J. Cereb. Blood Flow Metab., 1999; 19: 351-369. (Pubitemid 30161223)
43. Gibson G.E., Ratan R.R., Beal M.F.: Mitochondria and oxidative stress in neurodegenerative disorders. Ann. NY Acad. Sci., 2008; 1147: xi-xii.
44. Gilgun-Sherki Y., Melamed E., Offen D.: Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology, 2001; 40: 959-975. (Pubitemid 32530602)
45. Gondko R.: Czy przemiany rodników tlenowych w organizmie przebiegaja cyklicznie? Postepy Biochemii, 1995; 41: 243-247.
46. Greenamyre J.T., Betarbet R., Sherer T.B.: The rotenone model of Parkinson's disease: genes, environment and mitochondria. Parkinsonism Relat. Disord., 2003; 9: S59-S64. (Pubitemid 36952523)
47. Guzmán M., Blázquez C.: Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol. Metab., 2001; 12: 169-173. (Pubitemid 33713558)
48. Halliwell B.: Reactive oxygen species and the central nervous system. J. Neurochem., 1992; 59: 1609-1623.
49. Halliwell B.: Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging, 2001; 18: 685-716. (Pubitemid 32948277)
50. Halliwell B., Clement M.V., Long L.H.: Hydrogen peroxide in the human body. FEBS Lett., 2000; 486: 10-13.
51. Hirrlinger J., Schulz J.B., Dringen R.: Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease. J. Neurochem., 2002; 82: 458-467. (Pubitemid 34831487)
52. Ischiropoulos H., Beckman J.S.: Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest., 2003; 111: 163-169. (Pubitemid 36105911)
53. Jenner P.: Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci., 2001; 24: 245-247.
54. Johannessen J.N., Markey S.P.: Assessment of the opiate properties of two constituents of a toxic illicit drug mixture. Drug Alcohol Depend., 1984; 13: 367-374. (Pubitemid 14091245)
55. Kim Y.S., Joh T.H.: Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp. Mol. Med., 2006; 38: 333-347.
56. Kopczynska E., Torlinski L., Ziółkowski M.: Wpływ uzaleznienia od alkoholu na parametry stresu oksydacyjnego. Postepy Hig. Med. Dosw., 2001; 55: 95-111.
57. Koppal T., Drake J., Butterfield D.A.: In vivo modulation of rodent glutathione and its role in peroxynitrite-induced neocortical synaptosomal membrane protein damage. Biochim. Biophys. Acta, 1999; 1453: 407-411. (Pubitemid 29146165)
58. Koppenol W.H.: The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic. Biol. Med., 1998; 25: 385-391. (Pubitemid 28390296)
59. Law A., Gauthier S., Quirion R.: Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Brain Res. Rev., 2001; 35: 73-96. (Pubitemid 32201877)
60. Levine R.L., Stadtman E.R.: Oxidative modification of proteins during aging. Exp. Gerontol., 2001; 36: 1495-1502. (Pubitemid 32768727)
61. Li H., Guo M.: Protein degradation in Parkinson disease revisited: it's complex. J. Clin. Invest., 2009; 119: 442-445.
62. Liczmanski A.E.: Toksycznosc tlenu. Uszkodzenie zywych komórek. Postepy Biochemii, 1988; 34: 273-291.
63. Litvinov D.I., Dubovaia V.I., Vasil'ev M.G., Lekishvili M.V., Prasolov V.S., Turpaev K.T.: Effect of catalase on the expression of NO-dependent genes in primary chondrocytes. Mol. Biol., 2003; 37: 482-485.
64. Liu P.K., Robertson C.S., Valadka A.: The association between neuronal nitric oxide synthase and neuronal sensitivity in the brain after brain injury. Ann. N Y Acad. Sci., 2002; 962: 226-241. (Pubitemid 34592315)
65. Lovell M.A., Xie C., Markesbery W.R.: Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology, 1998; 51: 1562-1566. (Pubitemid 28565232)
66. Mahadik S.P., Mukherjee S.: Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr. Res., 1996; 19: 1-17. (Pubitemid 26133208)
67. Mann C.L., Davies M.B., Boggild M.D., Alldersea J., Fryer A.A., Jones P.W., Ko Ko C., Young C., Strange R.C., Hawkins C.P.: Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology, 2000; 54: 552-557. (Pubitemid 30082917)
68. Maragos W.F., Young K.L., Altman C.S., Pocernich C.B., Drake J., Butterfield D.A., Seif I., Holschneider D.P., Chen K., Shih J.C.: Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochem. Res., 2004; 29: 741-746. (Pubitemid 38429192)
69. Mariani E., Polidori M.C., Cherubini A., Mecocci P.: Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2005; 827: 65-75. (Pubitemid 41551598)
70. Markesbery W.R., Carney J.M.: Oxidative alterations in Alzheimer's disease. Brain Pathol., 1999; 9: 133-146. (Pubitemid 29056524)
71. Marnett L.J.: Oxy radicals, lipid peroxidation and DNA damage. Toxicology, 2002; 181-182: 219-222. (Pubitemid 36015702)
72. Marnett L.J., Riggins J.N., West J.D.: Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest., 2003; 111: 583-593. (Pubitemid 36278574)
73. McCord J.M.: The evolution of free radicals and oxidative stress. Am. J. Med., 2000; 108: 652-659. (Pubitemid 30336605)
74. Mecocci P., MacGarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.C., Beal M.F.: Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol., 1993; 34: 609-616. (Pubitemid 23289414)
75. Mogi M., Togari A., Kondo T., Mizuno Y., Komure O., Kuno S., Ichinose H., Nagatsu T.: Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J. Neural. Transm., 2000; 107: 335-341. (Pubitemid 30162695)
76. Muchová J., Sustrová M., Garaiová I., Liptáková A., Blazícek P., Kvasnicka P., Pueschel S., Duracková Z.: Influence of age on activities of antioxidant enzymes and lipid peroxidation products in eryth-rocytes and neutrophils of Down syndrome patients. Free Radic. Biol. Med., 2001; 31: 499-508. (Pubitemid 32728437)
77. Niki E., Yoshida Y., Saito Y., Noguchi N.: Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem. Biophys. Res. Commun., 2005; 338: 668-676. (Pubitemid 41540614)
78. Ohshima H.: Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol. Lett., 2003; 140-141: 99-104. (Pubitemid 36378927)
79. Okado-Matsumoto A., Fridovich I.: Amyotrophic lateral sclerosis: a proposed mechanism. Proc. Natl. Acad. Sci. USA, 2002; 99: 9010-9014. (Pubitemid 34693674)
80. Oszajca K., Szemraj J., Bartkowiak J.: Udział tlenku azotu w regulacji ekspresji genów. Postepy Biochemii, 2007; 53: 254-262.
81. Palumbo A., Napolitano A., Barone P., d'Ischia M.: Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration. Chem. Res. Toxicol., 1999; 12: 1213-1222. (Pubitemid 30013532)
82. Peuchen S., Bolaños J.P., Heales S.J., Almeida A., Duchen M.R., Clark J.B.: Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol., 1997; 52: 261-281. (Pubitemid 27306870)
83. Pfeiffer S., Schmidt K., Mayer B.: Dityrosine formation outcompetes tyrosine nitration at low steady-state concentrations of peroxynitrite. Implications for tyrosine modification by nitric oxide/superoxide in vivo. J. Biol. Chem., 2000; 275: 6346-6352. (Pubitemid 30129928)
84. Ponczek M.B., Wachowicz B.: Oddziaływanie reaktywnych form tlenu i azotu z bialkami. Postepy Biochemii, 2005; 51: 40-45.
85. Porter N.A., Caldwell S.E., Mills K.A.: Mechanisms of free radical oxidation of unsaturated lipids. Lipids, 1995; 30: 277-290.
86. Provost C., Choufani F., Avedanian L., Bkaily G., Gobeil F., Jacques D.: Nitric oxide and reactive oxygen species in the nucleus revisited. Can. J. Physiol. Pharmacol., 2010; 88: 296-304.
87. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Davignon J., Quirion R., Poirier J.: Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic. Biol. Med., 1999; 27: 544-553. (Pubitemid 29408640)
88. Ravindranath V.: Metabolism of xenobiotics in the central nervous system: implications and challenges. Biochem. Pharmacol., 1998; 56: 547-551. (Pubitemid 28458892)
89. Roediger B., Armati P.J.: Oxidative stress induces axonal beading in cultured human brain tissue. Neurobiol. Dis., 2003; 13: 222-229. (Pubitemid 36937205)
90. Rotilio G., Aquilano K., Ciriolo M.R.: Interplay of Cu, Zn superoxide dismutase and nitric oxide synthase in neurodegenerative processes. IUBMB Life, 2003; 55: 629-634. (Pubitemid 38019842)
91. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H.: Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J., 1998; 17: 2596-2606. (Pubitemid 28221195)
92. Sawicki W.T.: Histologia. Wydawnictwo lekarskie PZWL, 2008.
93. Sayre L.M., Perry G., Smith M.A.: Oxidative stress and neurotoxicity. Chem. Res. Toxicol., 2008; 21: 172-188. (Pubitemid 351219718)
94. Scandalios J.G.: Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz. J. Med. Biol. Res., 2005; 38: 995-1014. (Pubitemid 41078961)
95. Sheline Y.I.: Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity? Mol. Psychiatry, 1996; 1: 298-299.
96. Siegal G.L., Alberts R.W., Brady S.T., Price D.L.: Neurocellular anatomy. Basic Neurochemistry. Molecular, cellular and medical aspects. Elsevier Academic Press, 2006.
97. Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H.: Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology, 2004; 62: 1758-1765. (Pubitemid 38661731)
98. Song H., Stevens C.F., Gage F.H.: Astroglia induce neurogenesis from adult neural stem cells. Nature, 2002; 417: 39-44. (Pubitemid 34498810)
99. Stadtman E.R., Levine R.L.: Protein oxidation. Ann. N Y Acad. Sci., 2000; 899: 191-208. (Pubitemid 30352787)
100. Stoian I., Oros A., Moldoveanu E.: Apoptosis and free radicals. Biochem. Mol. Med., 1996; 59: 93-97. (Pubitemid 27036496)
101. Sullivan P.G., Brown M.R.: Mitochondrial aging and dysfunction in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2005; 29: 407-410. (Pubitemid 40417592)
102. Svenningsson A., Petersson A.S., Andersen O., Hansson G.K.: Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course. Neurology, 1999; 53: 1880-1882. (Pubitemid 29530375)
103. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C.: Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol., 1999; 46: 129-131. (Pubitemid 29314394)
104. Tylec A., Jarzab A., Stryjecka-Zimmer M., Wójcicka A.: Stres oksydacyjny w schizofrenii. Pol. Merk. Lek., 2007; 23(133): 74-77.
105. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J.: Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007; 39: 44-84. (Pubitemid 44566469)
106. Vila M., Przedborski S.: Genetic clues to the pathogenesis of Parkinson's disease. Nat. Med., 2004; 10: S58-S62. (Pubitemid 38901868)
107. Weintraub D., Comella C.L., Horn S.: Parkinson's disease - Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am. J. Manag. Care, 2008; 14: S40-S48. (Pubitemid 351451787)
108. Youdim M.B., Bakhle Y.S.: Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br. J. Pharmacol., 2006; 147: S287-S296. (Pubitemid 43077287)
109. Zajdel A., Wilczok A., Slowinski J., Orchel J., Mazurek U.: Aldehydic lipid peroxidation products in human brain astrocytomas. J. Neurooncol., 2007; 84: 167-173. (Pubitemid 47202125)
110. Zasadowski A., Wysocki A.D., Barski D., Spodniewska A.: Some aspects of reactive oxygen species (ROS) and antioxidative system agent's action. Short review. Acta Toxicol., 2004; 12: 5-19. (Pubitemid 39452495)
111. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.G., Montine T.J.: Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol., 1999; 154: 1423-1429. (Pubitemid 29226437)